Venn Life Sciences (LON:VENN) Shares Cross Below 200 Day Moving Average of $6.85

Venn Life Sciences Holdings PLC (LON:VENN)’s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 6.85 ($0.08) and traded as low as GBX 6.70 ($0.08). Venn Life Sciences shares last traded at GBX 6.85 ($0.08), with a volume of 1,027,544 shares traded.

Venn Life Sciences Price Performance

The company has a debt-to-equity ratio of 35.83, a current ratio of 2.30 and a quick ratio of 1.48. The business has a 50 day simple moving average of GBX 6.85 and a 200 day simple moving average of GBX 6.85. The company has a market capitalization of £4.89 million and a price-to-earnings ratio of -2.14.

Venn Life Sciences Company Profile

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.